BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14512166)

  • 1. Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat disease.
    Eltayeb S; Sunnemark D; Berg AL; Nordvall G; Malmberg A; Lassmann H; Wallström E; Olsson T; Ericsson-Dahlstrand A
    J Neuroimmunol; 2003 Sep; 142(1-2):75-85. PubMed ID: 14512166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
    Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
    J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of the chemokine receptors CX3CR1 and CCR1 by microglia and macrophages in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis.
    Sunnemark D; Eltayeb S; Wallström E; Appelsved L; Malmberg A; Lassmann H; Ericsson-Dahlstrand A; Piehl F; Olsson T
    Brain Pathol; 2003 Oct; 13(4):617-29. PubMed ID: 14655765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.
    Matsui M; Weaver J; Proudfoot AE; Wujek JR; Wei T; Richer E; Trapp BD; Rao A; Ransohoff RM
    J Neuroimmunol; 2002 Jul; 128(1-2):16-22. PubMed ID: 12098506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
    Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression.
    Fischer FR; Santambrogio L; Luo Y; Berman MA; Hancock WW; Dorf ME
    J Neuroimmunol; 2000 Oct; 110(1-2):195-208. PubMed ID: 11024550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE.
    Adamus G; Manczak M; Machnicki M
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2894-903. PubMed ID: 11687534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental autoimmune encephalomyelitis on the SJL mouse: effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system.
    Rajan AJ; Asensio VC; Campbell IL; Brosnan CF
    J Immunol; 2000 Feb; 164(4):2120-30. PubMed ID: 10657666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions.
    Merkler D; Schmelting B; Czéh B; Fuchs E; Stadelmann C; Brück W
    Mult Scler; 2006 Aug; 12(4):369-74. PubMed ID: 16900750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions.
    Mahad DJ; Trebst C; Kivisäkk P; Staugaitis SM; Tucky B; Wei T; Lucchinetti CF; Lassmann H; Ransohoff RM
    J Neuropathol Exp Neurol; 2004 Mar; 63(3):262-73. PubMed ID: 15055450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of chemokine signaling in patients with multiple sclerosis.
    Zipp F; Hartung HP; Hillert J; Schimrigk S; Trebst C; Stangel M; Infante-Duarte C; Jakobs P; Wolf C; Sandbrink R; Pohl C; Filippi M;
    Neurology; 2006 Nov; 67(10):1880-3. PubMed ID: 17130431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent.
    Rottman JB; Slavin AJ; Silva R; Weiner HL; Gerard CG; Hancock WW
    Eur J Immunol; 2000 Aug; 30(8):2372-7. PubMed ID: 10940928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells.
    Parker LC; Whyte MK; Vogel SN; Dower SK; Sabroe I
    J Immunol; 2004 Apr; 172(8):4977-86. PubMed ID: 15067079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
    Coates PT; Colvin BL; Ranganathan A; Duncan FJ; Lan YY; Shufesky WJ; Zahorchak AF; Morelli AE; Thomson AW
    Kidney Int; 2004 Nov; 66(5):1907-17. PubMed ID: 15496162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel non-peptide CCR1 receptor antagonists.
    Ng HP; May K; Bauman JG; Ghannam A; Islam I; Liang M; Horuk R; Hesselgesser J; Snider RM; Perez HD; Morrissey MM
    J Med Chem; 1999 Nov; 42(22):4680-94. PubMed ID: 10579830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response.
    Lobell A; Weissert R; Eltayeb S; de Graaf KL; Wefer J; Storch MK; Lassmann H; Wigzell H; Olsson T
    J Immunol; 2003 Feb; 170(4):1806-13. PubMed ID: 12574345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice.
    Repeke CE; Ferreira SB; Claudino M; Silveira EM; de Assis GF; Avila-Campos MJ; Silva JS; Garlet GP
    Bone; 2010 Apr; 46(4):1122-30. PubMed ID: 20053385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes.
    Weissert R; Wiendl H; Pfrommer H; Storch MK; Schreiner B; Barth S; Seifert T; Melms A; Dichgans J; Weller M
    J Neuroimmunol; 2003 Nov; 144(1-2):28-37. PubMed ID: 14597095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR1 chemokine receptor antagonist.
    Saeki T; Naya A
    Curr Pharm Des; 2003; 9(15):1201-8. PubMed ID: 12769747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis.
    Fife BT; Paniagua MC; Lukacs NW; Kunkel SL; Karpus WJ
    J Neurosci Res; 2001 Nov; 66(4):705-14. PubMed ID: 11746391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.